InMed Pharmaceuticals Inc. (INM) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 659.85M | 1.13M | 1.12M | 1.78M | 1.26M | 1.11M | 1.26M | 1.28M | 1.17M | 1.24M | 901.86K | 3.06M | 1.03M | 636.06K | 443.06K | 514.76K | 309.58K | 335.22K | 0 | 0 |
| Revenue Growth % | 52203.39% | 1.23% | -11.43% | 38.51% | 7.59% | -10.36% | 40.23% | -58.09% | 13.41% | 94.98% | 103.55% | 494.75% | 233.97% | 89.75% | - | - | - | - | - | - |
| Cost of Goods Sold | 134.66K | 1.09M | 716.96K | 991.69K | 1.09M | 650.81K | 771.23K | 817K | 883.14K | 916.06K | 880.62K | 981.21K | 984.04K | 458.47K | 1.12M | 409.57K | 270.1K | 194.15K | 0 | 0 |
| COGS % of Revenue | 0.02% | 96.81% | 64.01% | 55.8% | 86.08% | 58.54% | 60.98% | 63.68% | 75.31% | 73.86% | 97.64% | 32.05% | 95.17% | 72.08% | 253.07% | 79.57% | 87.25% | 57.92% | - | - |
| Gross Profit | -134.66K | 35.91K | 403.16K | 785.47K | 175.63K | 460.89K | 493.41K | 466.07K | 289.46K | 324.14K | 21.24K | 2.08M | 49.89K | 177.59K | -678.17K | 105.19K | 39.49K | 141.06K | 0 | 0 |
| Gross Margin % | -0.02% | 3.19% | 35.99% | 44.2% | 13.92% | 41.46% | 39.02% | 36.32% | 24.69% | 26.14% | 2.36% | 67.95% | 4.83% | 27.92% | -153.07% | 20.43% | 12.75% | 42.08% | - | - |
| Gross Profit Growth % | -176.67% | -92.21% | -18.29% | 68.53% | -39.33% | 42.19% | 2222.82% | -77.6% | 480.23% | 82.52% | 103.13% | 1877.69% | 26.34% | 25.89% | - | - | - | - | - | - |
| Operating Expenses | 2.68M | 2.95M | 2.17M | 3.22M | 2.29M | 2.67M | 2.25M | 2.48M | 2.09M | 2.03M | 21.24K | 2.69M | 2.2M | 3.14M | 4.06M | 3.15M | 3.58M | 5.53M | 2.89M | 3.31M |
| OpEx % of Revenue | 0.41% | 261.76% | 193.45% | 181.35% | 181.59% | 239.92% | 177.73% | 192.9% | 177.86% | 163.6% | 2.36% | 87.98% | 212.69% | 493.04% | 916.22% | 612.44% | 1156.1% | 1649.94% | - | - |
| Selling, General & Admin | 240.12M | 2.08M | 1.53M | 3.07M | 1.33M | 1.55M | 1.42M | 1.21M | 1.37M | 1.36M | 1.3M | 1.87M | 1.32M | 1.98M | 2.16M | 1.65M | 1.83M | 2.32M | 1.37M | 1.56M |
| SG&A % of Revenue | 36.39% | 184.87% | 136.77% | 172.71% | 105.34% | 139.75% | 112.44% | 94.61% | 117.18% | 109.98% | 144.01% | 60.99% | 127.75% | 311.82% | 486.45% | 320.89% | 589.68% | 692.89% | - | - |
| Research & Development | 1.02M | 865.31K | 581.61K | 153.54K | 909.65K | 1.06M | 771.18K | 1.21M | 656.76K | 609.79K | 1.29M | 826.29K | 878.3K | 1.15M | 1.9M | 1.5M | 1.75M | 3.21M | 1.49M | 1.72M |
| R&D % of Revenue | 0.15% | 76.89% | 51.92% | 8.64% | 72.1% | 95.38% | 60.98% | 94.02% | 56.01% | 49.17% | 143.27% | 26.99% | 84.95% | 181.22% | 429.77% | 291.54% | 566.42% | 957.05% | - | - |
| Other Operating Expenses | -1000K | 0 | 53.2K | 0 | 52.31K | 53.2K | 54.58K | 54.77K | 54.77K | 55.23K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28.53K | 28.65K |
| Operating Income | -2.82M | -2.91M | -1.76M | -2.44M | -2.12M | -2.21M | -1.75M | -2.01M | -1.8M | -1.7M | 0 | -613.08K | -2.15M | -2.96M | -4.74M | -3.05M | -3.54M | -5.39M | -2.89M | -3.31M |
| Operating Margin % | -0.43% | -258.57% | -157.45% | -137.15% | -167.67% | -198.46% | -138.72% | -156.58% | -153.18% | -137.47% | - | -20.03% | -207.87% | -465.12% | -1069.29% | -592% | -1143.35% | -1607.86% | - | - |
| Operating Income Growth % | -33.14% | -31.89% | -0.54% | -21.32% | -17.77% | -29.41% | - | -227.69% | 16.43% | 42.37% | 100% | 79.88% | 39.28% | 45.11% | -63.78% | 7.83% | -12.95% | -178.64% | -84.96% | -58.84% |
| EBITDA | -2.68M | -2.69M | -1.61M | -2.37M | -1.99M | -2.08M | -1.61M | -1.86M | -1.65M | -1.55M | -2.48M | -542.26K | -2.01M | -2.89M | -4.67M | -2.9M | -3.4M | -5.33M | -2.84M | -3.28M |
| EBITDA Margin % | -0.41% | -239.3% | -143.47% | -133.1% | -157.4% | -186.85% | -127.25% | -144.74% | -140.33% | -125.16% | -274.44% | -17.71% | -194.07% | -454.68% | -1054% | -563.93% | -1097.22% | -1589.08% | - | - |
| EBITDA Growth % | -35.05% | -29.65% | 0.14% | -27.37% | -20.68% | -33.82% | 34.98% | -242.48% | 18% | 46.33% | 47% | 81.32% | 40.93% | 45.71% | -64.53% | 11.43% | -10.33% | -190.06% | -84.79% | -60.27% |
| D&A (Non-Cash Add-back) | 134.66K | 216.82K | 156.68K | 71.85K | 129.58K | 129.08K | 144.98K | 151.86K | 150.69K | 152.61K | 149.36K | 70.82K | 142.62K | 66.41K | 67.74K | 144.52K | 142.79K | 62.97K | 54.44K | 28.65K |
| EBIT | -2.82M | -2.91M | -1.73M | -2.51M | -2.12M | -2.22M | -1.75M | -2.01M | -1.72M | -1.48M | -2.62M | -683.91K | -2M | -3.02M | -4.81M | -7.87M | -3.48M | -5.45M | -2.89M | -3.26M |
| Net Interest Income | 47.77K | 102.06K | 93.77K | 31.69K | 16.64K | -321.01K | 56.83K | 141.74K | 164.82K | 221.04K | 184.23K | 196.81K | 210.31K | 155.59K | 99.5K | 43.39K | 38.69K | 33.49K | 6.52K | 5.97K |
| Interest Income | 47.77K | 102.06K | 93.77K | 51.69K | 16.64K | 30.54K | 56.83K | 141.74K | 164.82K | 221.04K | 184.23K | 196.81K | 210.31K | 155.59K | 99.5K | 43.39K | 38.69K | 33.49K | 6.52K | 5.97K |
| Interest Expense | 0 | 0 | 0 | 20K | 0 | 351.55K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 24.6K | 126.94K | 36.77K | 1.46K | -5.6K | -368.77K | 76.4K | 78.44K | 73.3K | 226.66K | -2.54M | 167.19K | 152.76K | 117.77K | -101.17K | -4.82M | 63.96K | -25.94K | -78.96K | 47.55K |
| Pretax Income | -2.79M | -2.78M | -1.73M | -2.44M | -2.12M | -2.58M | -1.68M | -1.93M | -1.72M | -1.48M | -2.54M | -445.89K | -2M | -2.84M | -4.84M | -7.87M | -3.48M | -5.42M | -2.97M | -3.26M |
| Pretax Margin % | -0.42% | -247.29% | -154.17% | -137.07% | -168.12% | -231.63% | -132.68% | -150.47% | -146.93% | -119.19% | -281.29% | -14.56% | -193.09% | -446.61% | -1092.12% | -1528.88% | -1122.69% | -1615.6% | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.1K | 0 | 0 | 0 | 2.38K | 1.5K | 4.06K | 9.39K | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -0.37% | 0% | 0% | 0% | -0.53% | -0.08% | -0.14% | -0.19% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2.97M | -2.78M | -1.73M | -2.44M | -2.12M | -2.58M | -1.68M | -1.94M | -1.72M | -1.48M | -2.54M | -448.28K | -2M | -2.84M | -4.85M | -7.87M | -3.48M | -5.42M | -2.97M | -3.26M |
| Net Margin % | -0.45% | -247.29% | -154.17% | -137.07% | -168.12% | -231.63% | -132.68% | -151.02% | -146.93% | -119.19% | -281.29% | -14.64% | -193.24% | -447.25% | -1094.24% | -1528.88% | -1122.69% | -1615.6% | - | - |
| Net Income Growth % | -39.86% | -8.08% | -2.92% | -25.71% | -23.1% | -74.2% | 33.86% | -332.25% | 13.77% | 48.04% | 47.67% | 94.3% | 42.52% | 47.47% | -63.15% | -141.5% | -12.06% | -141.37% | -85.83% | -48.51% |
| Net Income (Continuing) | -2.79M | -2.78M | -1.73M | -2.44M | -2.12M | -2.58M | -1.68M | -1.94M | -1.72M | -1.48M | -2.54M | -448.28K | -2M | -2.84M | -4.85M | -7.87M | -3.48M | -5.42M | -2.97M | -3.26M |
| Discontinued Operations | -174.59K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.73 | -703.84 | -436.75 | -1.22 | -1.94 | -3.64 | -2.71 | -4.35 | -3.58 | -3.71 | -15.24 | -2.69 | -12.01 | -24.73 | -112.02 | -219.88 | -122.80 | -195.56 | -123.33 | -202.39 |
| EPS Growth % | 62.37% | -19236.26% | -16016.24% | 71.95% | 45.81% | 1.89% | 82.22% | -61.71% | 70.19% | 85% | 86.4% | 98.78% | 90.22% | 87.35% | 9.17% | -8.64% | 40.22% | -6.17% | 19.47% | 3.7% |
| EPS (Basic) | -0.73 | -703.84 | -436.75 | -1.22 | -1.94 | -3.64 | -2.71 | -4.35 | -3.58 | -3.71 | -15.24 | -2.69 | -12.01 | -24.73 | -112.02 | -219.88 | -122.80 | -195.56 | -123.33 | -202.39 |
| Diluted Shares Outstanding | 4.05M | 3.95K | 3.95K | 2M | 1.1M | 706.55K | 620.13K | 445.95K | 480.65K | 398.67K | 166.41K | 166.41K | 166.41K | 115.03K | 43.28K | 35.79K | 28.3K | 27.69K | 24.09K | 16.1K |
| Basic Shares Outstanding | 4.05M | 3.95K | 3.95K | 2M | 1.1M | 706.55K | 620.13K | 445.95K | 480.65K | 398.67K | 166.41K | 166.41K | 166.41K | 115.03K | 43.28K | 35.79K | 28.3K | 27.69K | 24.09K | 16.1K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |